CARE reaffirms ratings of Cipla’s bank facilities

07 Jan 2015 Evaluate

Credit rating agency, CARE has reaffirmed ‘AAA’ rating to Cipla’s long term fund based bank facilities worth RS 60.09 crore. The rating agency has assigned ‘AAA’ rating to short term fund based bank facilities of the bank, while reaffirmed ‘A1+’ rating to the bank’s short term non fund based bank facilities worth Rs 58.41 crore.

The reaffirmation of ratings assigned to bank facilities of Cipla derives strength from its reputed brand having global presence, well established and experienced promoters, dominant market position in domestic pharmaceutical industry, robust operational performance and strong financial risk profile.

Cipla has emerged as one of the most respected pharmaceutical names in India as well as across more than 170 countries. Its portfolio includes 2000 products in 65 therapeutic categories with one quality standard globally.

Cipla Share Price

1520.55 -0.65 (-0.04%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×